Search

everythinglearnresearchcommunity

for

Search:↓

Terminalia chebula fruit extract helps hair growth by reducing DHT and boosting hair cell activity.

Combining new technologies and practices can improve food systems to meet global sustainability goals.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

The document's content could not be processed.

The document's content could not be processed.

The document's content could not be processed.

Adipose-derived stem cells can help repair and improve eye tissues and appearance.

Technology, like stem cell therapy and teledermatology, is improving dermatology care.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

FFA in men shows unique features and treatment results vary widely.

Zinc sulfide cellulose scaffolds can reduce scarring and promote hair growth.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Finasteride, a medication, is being re-evaluated for its effects and uses.

Frontal fibrosing alopecia has occurred in two related male families.

Stem cell treatment improved hair density in female hair loss patient.

The conclusion cannot be provided because the document content is not available.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.